Handbook of Psychiatric Drugs is a comprehensive, clear, concise and quick reference to psychiatric drug therapies, designed to guide the clinician on the selection and implementation of treatment for mental illness.

Features:

• Organised by drug class and follows a standard format for ease of use
• Details drug selection, initiation and maintenance of treatment and withdrawal
• Includes adverse effects, contraindications and drug interactions
• Makes it easy to keep up-to-date with new developments

Contents

Antipsychotic Drugs

• Pharmacology
• Chemistry
• Mechanism of Action
• Pharmacokinetics
• Indications for Use of Antipsychotic Drugs
• Drug Selection and Initiation of Treatment
• Drug Selection for the Treatment of Schizophrenia
• Effects of Antipsychotic Agents on Symptoms of Schizophrenia
• Drug Selection for the Treatment of Bipolar Disorder
• Drug Selection for the Treatment of Major Depression With Psychotic Features
• Drug Selection for the Treatment of Delusional Disorder
• Drug Selection for the Treatment of Delirium
• Drug Selection for the Treatment of Psychosis and Agitation Associated with Dementia
• Drug Selection for the Treatment of Mental Retardation and Developmental Disorders
• Drug Selection for Huntington’s Disease and Tourette’s Disorder
• Substance-induced Psychoses
• Adverse Effects of Antipsychotics
• Acute Extrapyramidal Side Effects (Dystonia, Parkinsonism, Akathisia)
• Tardive Dyskinesia and Other Tardive Syndromes
• Neuroleptic Malignant Syndrome
• Endocrine and Sexual Effects
• Metabolic Effects
• Cardiovascular Effects
• Gastrointestinal Effects
• Hepatic Effects
• Hematological Effects
• Other Side Effects
• Drug Interactions and Antipsychotic Agents
• Antipsychotic Medications and Pregnancy

Antidepressants

• Pharmacology
• Mechanisms of Action
• Pharmacokinetics
• Indications for Use of Antidepressants
• Panic Disorder (PD)
• Obsessive–Compulsive Disorder (OCD)
• Generalized Anxiety Disorder (GAD)
• Social Phobias and Posttraumatic Stress Disorder (PTSD)
• Bulimia
• Anorexia Nervosa
• Body Dysmorphic Disorder (BDD)
• Premenstrual Dysphoria (PMDD)
• Childhood Disorders
• Other Psychiatric Disorders
• Other Medical Conditions
• Drug Selection and Initiation of Treatment for Major Depression
• Special Considerations in the Selection of an Antidepressant
• Initiation of Treatment
• Therapeutic Drug Monitoring
• Early, or Pre-response, Period
• Response, or Acute Treatment, Period
• Treatment of Partially Responsive and Nonresponsive Patients
• Antidepressant Augmentation
• Changing to a New Agent
• Continuation and Maintenance Periods, and Discontinuation
• Side Effects
• Anticholinergic Effects
• Autonomic Effects
• Neurologic Effects
• Weight Gain
• Gastrointestinal Symptoms
• Sexual Dysfunction
• Cardiac Conduction
• Suicide Risk
• Allergic and Hematologic Effects
• Central Serotonergic Syndrome
• Monoamine Oxidase Inhibitors
• Drug Interactions
• Tricyclic Antidepressants
• Pharmacokinetic Effects
• Monoamine Oxidase Inhibitors
• Serotonin Reuptake Inhibitors
• Other Second-Generation Antidepressants
• Third-Generation Antidepressants

Mood Stabilizers

• Pharmacology
• Chemistry
• Mechanism of Action
• Pharmacokinetics
• Indications
• Drug Selection and Initiation of Treatment
• Acute Mania
• Drug Selection
• Relative Efficacy of Different Agents
• Treatment Initiation and Dose Titration
• Acute Depression
• Drug Selection
• Treatment Initiation and Dose Titration
• Breakthrough Episodes
• Maintenance
• Rapid Cycling
• Costs
• Adverse Effects
• Drug Interactions
• Pregnancy

Anxiolytic Drugs

• A General Approach to Using Medication with Anxious Patients
• Pharmacology
• Antidepressants
• Benzodiazepines
• Buspirone
• Beta-Blocker Medications
• Anticonvulsants
• Antipsychotics
• Indications for Use
• Antidepressants
• Benzodiazepines
• Buspirone
• Beta-blocker Medications
• Anticonvulsants
• Antipsychotics
• Augmentation/Adjuvant Treatments.
• Drug Selection, Dose, and Initiation of Treatment
• Side Effects
• Drug Interactions
• Contraindications and Special Precautions

Sedative–Hypnotic Agents

• Non-prescription Agents
• Prescription Medications
• Pharmacology
• Benzodiazepines
• Chloral Hydrate
• Zolpidem
• Zaleplon
• Eszopiclone
• Ramelteon
• Drug Selection
• Other Prescription Hypnotics
• Treatment Implementation
• Adverse Effects
• Benzodiazepines
• Chloral Hydrate
• Zolpidem
• Zaleplon
• Eszopiclone
• Ramelteon

Psychostimulants

• Pharmacology
• Chemistry
• Mechanism of Action
• Pharmacokinetics
• Indications and Contraindications
• Drug Selection
• Treatment Initiation and Dose Titration
• Treatment Evaluation
• Maintenance Treatment
• Treatment Resistance
• Effects of Treatment on Symptoms
• ADHD in Adults
• Alternative Preparations to the Standard Stimulant Medications
• Narcolepsy

Cognitive Enhancers and Treatments for Alzheimer’s Disease

• Pharmacology
• Mechanism of Action
• Pharmacokinetics
• Indications
• Drug Selection
• Treatment Initiation
• Maintenance Treatment
• Treatment Evaluation

Drugs for Treating Substance Abuse Disorders

• Syndromes Associated with Intoxication
• Alcohol Intoxication
• Sedative–Hypnotic Intoxication
• Opiate Intoxication
• Cocaine and Amphetamine Intoxication
• Intoxication by LSD, Mescaline, MDMA (‘Ecstasy’), and Psilocybin
• Phencyclidine Intoxication
• Drug Treatment of Withdrawal Syndromes
• Alcohol Withdrawal
• Withdrawal from Sedative–Hypnotics
• Withdrawal from Opiates
• Management of Withdrawal in Patients with Multiple Dependencies
• Agents to Aid Relapse Prevention
• Medications for Alcohol Dependence
• Medications for Cocaine Dependence
• Medications for Opiate Dependence
• Special Considerations
• Drug Treatments for Nicotine Dependence
• Pharmacotherapies for Substance Abusers with Additional Psychiatric Illness
• Pharmacotherapy for Specific Psychiatric Disorders
• Drug Interactions in Chemical Dependency

Index

click here to see books • videos • cd-roms of related interest